Cargando…
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
OBJECTIVE: It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational studies varied, and summary estimates are urgently needed to elucidate whet...
Autores principales: | Flacco, Maria Elena, Acuti Martellucci, Cecilia, Bravi, Francesca, Parruti, Giustino, Cappadona, Rosaria, Mascitelli, Alfonso, Manfredini, Roberto, Mantovani, Lorenzo G, Manzoli, Lamberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371482/ https://www.ncbi.nlm.nih.gov/pubmed/32611676 http://dx.doi.org/10.1136/heartjnl-2020-317336 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2 Lethality Did not Change Over Time in Two Italian Provinces
por: Flacco, Maria Elena, et al.
Publicado: (2020) -
SARS-CoV-2 pandemic: An overview
por: Acuti Martellucci, Cecilia, et al.
Publicado: (2020) -
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
por: Bravi, Francesca, et al.
Publicado: (2020) -
Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019) -
Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age
por: Bergh, Cecilia, et al.
Publicado: (2015)